DaVita Inc. (NYSE:DVA) Given Average Rating of “Hold” by Analysts

Shares of DaVita Inc. (NYSE:DVA) have earned an average recommendation of “Hold” from the six brokerages that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $166.33.

DVA has been the topic of several research analyst reports. Barclays raised their price objective on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. Cowen reaffirmed a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. StockNews.com lowered DaVita from a “buy” rating to a “hold” rating in a research note on Friday. Finally, Sanford C. Bernstein set a $184.00 price objective on DaVita in a research note on Friday, February 21st.

Hedge Funds Weigh In On DaVita

Large investors have recently bought and sold shares of the company. Copia Wealth Management bought a new stake in DaVita in the fourth quarter worth approximately $30,000. SBI Securities Co. Ltd. acquired a new stake in DaVita in the fourth quarter valued at approximately $41,000. Coppell Advisory Solutions LLC grew its stake in DaVita by 50.0% in the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company’s stock valued at $45,000 after acquiring an additional 100 shares during the period. Canada Post Corp Registered Pension Plan acquired a new stake in DaVita in the fourth quarter valued at approximately $55,000. Finally, Quarry LP acquired a new stake in DaVita in the third quarter valued at approximately $60,000. 90.12% of the stock is currently owned by institutional investors.

DaVita Stock Performance

DaVita stock opened at $148.25 on Friday. The stock has a 50-day simple moving average of $158.53 and a 200 day simple moving average of $157.48. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. DaVita has a 12-month low of $125.64 and a 12-month high of $179.60. The stock has a market capitalization of $11.86 billion, a price-to-earnings ratio of 13.80, a P/E/G ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last released its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, research analysts anticipate that DaVita will post 10.76 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.